Models of glaucomatous visual field loss.

PURPOSE To evaluate and compare the ability of pointwise linear, exponential, and logistic functions, and combinations of functions, to model the longitudinal behavior of visual field (VF) series and predict future VF loss in patients with glaucoma. METHODS Visual field series from 782 eyes (572 patients) with open-angle glaucoma had greater than 6 years of follow-up and 12 VFs performed. Threshold sensitivities from the first 5 years at each location were regressed with linear, exponential, and logistic functions to estimate model parameters. A multiple-model approach applied the model with the lowest root mean square error (RMSE) at each location as the preferred model for future predictions. Predictions for each model were compared at 1, 2, 3, and 5 years after the last VF used to determine model parameters. RESULTS There were no clinically important differences between any of the models tested for fit; however, the logistic function had the lowest average RMSE (P < 0.001). For predictions, the exponential model consistently had the lowest average prediction RMSE for all time intervals (P < 0.001); the multiple-model approach did not perform better than the exponential model (P < 0.001). CONCLUSIONS While the logistic model best fit glaucomatous VF behavior over a long time period, the exponential model provided the best average predictions. A multiple-model approach for VF predictions was associated with a greater prediction error than with the best-performing single-model approach. A model's goodness of fit is not indicative of its predictive ability for measurements of glaucomatous VFs.

[1]  Richard A. Russell,et al.  New Insights into Measurement Variability in Glaucomatous Visual Fields from Computer Modelling , 2013, PloS one.

[2]  Joseph Caprioli,et al.  The importance of rates in glaucoma. , 2008, American journal of ophthalmology.

[3]  Koenraad A Vermeer,et al.  Robust and censored modeling and prediction of progression in glaucomatous visual fields. , 2013, Investigative ophthalmology & visual science.

[4]  Robert Ritch,et al.  The rate of visual field change in the ocular hypertension treatment study. , 2012, Investigative ophthalmology & visual science.

[5]  S. Gardiner,et al.  Nonlinear, multilevel mixed-effects approach for modeling longitudinal standard automated perimetry data in glaucoma. , 2013, Investigative ophthalmology & visual science.

[6]  P. Lichter,et al.  The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. , 1999, Ophthalmology.

[7]  Parham Azarbod,et al.  Validation of point-wise exponential regression to measure the decay rates of glaucomatous visual fields. , 2012, Investigative ophthalmology & visual science.

[8]  M. Kass,et al.  The Ocular Hypertension Treatment Study: design and baseline description of the participants. , 1999, Archives of ophthalmology.

[9]  S. Gardiner,et al.  Examination of different pointwise linear regression methods for determining visual field progression. , 2002, Investigative ophthalmology & visual science.

[10]  R. A. Hitchings,et al.  Modelling series of visual fields to detect progression in normal-tension glaucoma , 1995, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  F. Medeiros,et al.  Improved Prediction of Rates of Visual Field Loss in Glaucoma Using Empirical Bayes Estimates of Slopes of Change , 2012, Journal of glaucoma.

[12]  Valter Torri,et al.  The European glaucoma prevention study design and baseline description of the participants. , 2002, Ophthalmology.

[13]  G. Spaeth,et al.  Visual field staging systems in glaucoma and the activities of daily living. , 2012, American journal of ophthalmology.

[14]  Paul H Artes,et al.  Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR). , 2012, Investigative ophthalmology & visual science.

[15]  D E Gaasterland,et al.  The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. , 1994, Controlled clinical trials.

[16]  Kouros Nouri-Mahdavi,et al.  A method to measure and predict rates of regional visual field decay in glaucoma. , 2011, Investigative ophthalmology & visual science.

[17]  A. Tafreshi,et al.  Incorporating risk factors to improve the assessment of rates of glaucomatous progression. , 2012, Investigative ophthalmology & visual science.